The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent acute coronary syndrome

Emily C Gathright, Katherine Diaz Vickery, Woubeshet Ayenew, Matthew C Whited, Melissa Adkins-Hempel, Michelle Chrastek, Jill K Carter, Rochelle K Rosen, Wen-Chih Wu, Andrew M Busch, Emily C Gathright, Katherine Diaz Vickery, Woubeshet Ayenew, Matthew C Whited, Melissa Adkins-Hempel, Michelle Chrastek, Jill K Carter, Rochelle K Rosen, Wen-Chih Wu, Andrew M Busch

Abstract

Background: Patients with acute coronary syndrome (ACS) with depressed mood demonstrate poor cardiovascular behavioral risk profiles and elevated risk for recurrent ACS and mortality. Behavioral Activation (BA) offers an intervention framework for an integrated treatment targeting both depression and critical health behaviors post-ACS. Behavioral Activation for Health and Depression (BA-HD) was developed and pilot tested in a multiphase iterative process.

Methods: First, an initial treatment manual was conceptualized based on the team's prior work, as well as the extant literature. Second, qualitative interviews were conducted with target patients and target providers on the proposed BA-HD treatment rationale, content, and structure. Framework matrix analyses were used to summarize and aggregate responses. Third, an expert panel was convened to elicit additional manual refinements. Finally, patients with post-ACS depression and health behavior non-adherence were recruited to complete an open pilot trial to evaluate acceptability (Client Satisfaction Questionnaire [CSQ], exit interview) and treatment engagement (number of sessions attended; treatment completion was considered completion of 8 out of 10 possible sessions).

Results: The initial BA-HD treatment manual expanded an existing treatment manual for post-ACS BA-based mood management and smoking cessation to target four health behaviors relevant to post-ACS patients (e.g., smoking cessation, medication adherence, physical activity, and diet). After the initial conceptualization, ten post-ACS patients and eight cardiac rehabilitation professionals completed qualitative interviews. Patients endorsed bi-directional interactions between mood and health behaviors post-ACS. Both patients and providers expressed general support of the proposed treatment rationale and values-guided, collaborative goal-setting approach. Patients, providers, and experts provided feedback that shaped the iterative manual development. After the BA-HD manual was finalized, eight participants were enrolled in a single-arm pilot trial. The mean CSQ score was 30.57 ± 2.23, indicating high satisfaction. Seven out of eight (88%) completed treatment. Pre- to post treatment improvements in depressed mood and health behaviors were promising.

Conclusions: BA-HD treatment is an acceptable approach to target both mood and health behaviors in post-ACS patients with depression. A future larger, controlled trial is needed to evaluate the efficacy of the BA-HD treatment.

Trial registration: ClinicalTrials.gov Identifier: NCT04158219.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Participant selection and study flow.
Fig 1. Participant selection and study flow.

References

    1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al.. Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation. 2020. Mar 3;141(9). doi: 10.1161/CIR.0000000000000757
    1. Jensen MK, Chiuve SE, Rimm EB, Dethlefsen C, Tjønneland A, Joensen AM, et al.. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation. 2008. Jun 17;117(24):3062–9. doi: 10.1161/CIRCULATIONAHA.107.759951
    1. Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010. Feb 16;121(6):750–8. doi: 10.1161/CIRCULATIONAHA.109.891523
    1. Celano CM, Huffman JC. Depression and cardiac disease: A review. Cardiol Rev. 2011. Jun;19(3):130–42. doi: 10.1097/CRD.0b013e31820e8106
    1. Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Post-myocardial infarction depression: Increased hospital admissions and reduced adoption of secondary prevention measures—A longitudinal study. J Psychosom Res. 2012. Jan;72(1):5–10. doi: 10.1016/j.jpsychores.2011.09.009
    1. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al.. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the American Heart Association. Circulation. 2014. Mar 25;129(12):1350–69. doi: 10.1161/CIR.0000000000000019
    1. Busch AM, Borrelli B, Leventhal AM. The relationship between smoking and depression post-acute coronary syndrome. Curr Cardiovasc Risk Rep. 2011. Dec;5(6):510–8.
    1. Sin NL, Kumar AD, Gehi AK, Whooley MA. Direction of association between depressive symptoms and lifestyle behaviors in patients with coronary heart disease: The Heart and Soul Study. Ann Behav Med. 2016. Aug;50(4):523–32. doi: 10.1007/s12160-016-9777-9
    1. Kronish IM, Rieckmann N, Burg MM, Edmondson D, Schwartz JE, Davidson KW. The effect of enhanced depression care on adherence to risk-reducing behaviors after acute coronary syndromes: Findings from the COPES trial. Am Heart J. 2012. Oct;164(4):524–9. doi: 10.1016/j.ahj.2012.07.024
    1. Roy MJ. Capsule commentary on Yeh, et al.., Depressed mood, perceived health competence and health behaviors: A cross-sectional mediation study in outpatients with coronary heart disease. J Gen Intern Med. 2019. Jul;34(7):1289–1289. doi: 10.1007/s11606-019-04917-8
    1. Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. PloS One. 2014;9(6):e100100. doi: 10.1371/journal.pone.0100100
    1. Kanter J, Busch A, Rusch L. Behavioral activation: distinctive features. London: Routledge; 2009. 184 p. (The CBT distinctive features).
    1. Choi NG, Pepin R, Marti CN, Stevens CJ, Bruce ML. Improving social connectedness for homebound older adults: Randomized controlled trial of tele-delivered behavioral activation versus tele-delivered friendly visits. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2020. Jul;28(7):698–708. doi: 10.1016/j.jagp.2020.02.008
    1. Tull MT, Berghoff CR, Bardeen JR, Schoenleber M, Konkle-Parker DJ. An initial open trial of a brief behavioral activation treatment for depression and medication adherence in HIV-infected patients. Behav Modif. 2018. Mar;42(2):196–209. doi: 10.1177/0145445517723901
    1. Ali MK, Chwastiak L, Poongothai S, Emmert-Fees KMF, Patel SA, Anjana RM, et al.. Effect of a collaborative care model on depressive symptoms and glycated hemoglobin, blood pressure, and serum cholesterol among patients with depression and diabetes in India: The INDEPENDENT Randomized Clinical Trial. JAMA. 2020. Aug 18;324(7):651. doi: 10.1001/jama.2020.11747
    1. Martínez-Vispo C, Rodríguez-Cano R, López-Durán A, Senra C, Fernández del Río E, Becoña E. Cognitive-behavioral treatment with behavioral activation for smoking cessation: Randomized controlled trial. Moitra E, editor. PLOS ONE. 2019. Apr 8;14(4):e0214252. doi: 10.1371/journal.pone.0214252
    1. Busch AM, Tooley EM, Dunsiger S, Chattillion EA, Srour JF, Pagoto SL, et al.. Behavioral activation for smoking cessation and mood management following a cardiac event: results of a pilot randomized controlled trial. BMC Public Health. 2017. Apr 17;17(1):323. doi: 10.1186/s12889-017-4250-7
    1. Ye S, Muntner P, Shimbo D, Judd SE, Richman J, Davidson KW, et al.. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol. 2013. Feb 12;61(6):622–30. doi: 10.1016/j.jacc.2012.09.058
    1. Chrysohoou C, Liontou C, Aggelopoulos P, Kastorini C-M, Panagiotakos D, Aggelis A, et al.. Mediterranean diet mediates the adverse effect of depressive symptomatology on short-term outcome in elderly survivors from an acute coronary event. Cardiol Res Pract. 2011;2011:1–8. doi: 10.4061/2011/429487
    1. Brummett BH, Babyak MA, Siegler IC, Mark DB, Williams RB, Barefoot JC. Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. Am J Cardiol. 2003. Sep;92(5):529–32. doi: 10.1016/s0002-9149(03)00719-7
    1. Richards SH, Dickens C, Anderson R, Richards DA, Taylor RS, Ukoumunne OC, et al.. Assessing the effectiveness of Enhanced Psychological Care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): a pilot cluster randomised controlled trial. Trials. 2018. Dec;19(1):211. doi: 10.1186/s13063-018-2576-9
    1. Busch AM, Fani Srour J, Arrighi JA, Kahler CW, Borrelli B. Valued Life Activities, Smoking Cessation, and Mood in Post-Acute Coronary Syndrome Patients. Int J Behav Med. 2015. Oct;22(5):563–8. doi: 10.1007/s12529-014-9456-9
    1. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013. Dec;13(1):117. doi: 10.1186/1471-2288-13-117
    1. Ekers DM, Dawson MS, Bailey E. Dissemination of behavioural activation for depression to mental health nurses: training evaluation and benchmarked clinical outcomes: BA training for mental health nurses. J Psychiatr Ment Health Nurs. 2013. Mar;20(2):186–92. doi: 10.1111/j.1365-2850.2012.01906.x
    1. Patel V, Weobong B, Weiss HA, Anand A, Bhat B, Katti B, et al.. The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: a randomised controlled trial. The Lancet. 2017. Jan;389(10065):176–85. doi: 10.1016/S0140-6736(16)31589-6
    1. Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: Development and refinement of a Service Evaluation Questionnaire. Eval Program Plann. 1983. Jan;6(3–4):299–313. doi: 10.1016/0149-7189(83)90010-1
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001. Sep;16(9):606–13. doi: 10.1046/j.1525-1497.2001.016009606.x
    1. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994. Apr;10(2):77–84.
    1. Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, et al.. The impact of patient adherence on health outcomes for patients with chronic disease in the medical outcomes study. J Behav Med. 1994. Aug;17(4):347–60. doi: 10.1007/BF01858007
    1. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000. Jun 26;160(12):1818. doi: 10.1001/archinte.160.12.1818
    1. Romanelli J, Fauerbach J, Bush D, Ziegelstein R. The significance of depression in older patients after myocardial infarction. J Am Geriatr Soc. 2002. May 1;50:817–22. doi: 10.1046/j.1532-5415.2002.50205.x
    1. Cutter GR, Burke GL, Dyer AR, Friedman GD, Hilner JE, Hughes GH, et al.. Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials. 1991. Feb;12(1 Suppl):1S–77S. doi: 10.1016/0197-2456(91)90002-4
    1. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005. Nov 28;165(21):2508–13. doi: 10.1001/archinte.165.21.2508
    1. O’Halloran P, Kingsley M, Nicholson M, Staley K, Randle E, Wright A, et al.. Responsiveness of the single item measure to detect change in physical activity. Weston KL, editor. PLOS ONE. 2020. Jun 25;15(6):e0234420. doi: 10.1371/journal.pone.0234420
    1. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000. Jul 1;23(7):943–50. doi: 10.2337/diacare.23.7.943
    1. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70. doi: 10.1037//0022-3514.54.6.1063
    1. Schneider KL, Panza E, Handschin B, Ma Y, Busch AM, Waring ME, et al.. Feasibility of pairing behavioral activation with exercise for women with type 2 diabetes and depression: The Get It Study pilot randomized controlled trial. Behav Ther. 2016. Mar;47(2):198–212. doi: 10.1016/j.beth.2015.10.005
    1. Araya R, Menezes PR, Claro HG, Brandt LR, Daley KL, Quayle J, et al.. Effect of a digital intervention on depressive symptoms in patients with comorbid hypertension or diabetes in Brazil and Peru: Two randomized clinical trials. JAMA. 2021. May 11;325(18):1852–62. doi: 10.1001/jama.2021.4348
    1. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al.. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005;111(3):369–76. doi: 10.1161/01.CIR.0000151788.08740.5C

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren